Of note, Plxna4, a semaphorin receptor involved in cytoskeletal remodeling and vascular permeability, has been shown to be reduced in coronary artery disease, with its suppression linked to increased vascular inflammation and endothelial barrier dysfunction [40]. Here, PLXNA4 is linked to coronary artery disorder.